Bruker Corporation is a scientific instruments and solutions company based in the United States. Founded in 1960 by physicist Dr. Günther Laukien, the company has grown to become a global leader in providing high-performance scientific instruments and analytical solutions to enable scientific research and development.

Headquartered in Billerica, Massachusetts, Bruker operates multiple divisions specializing in various segments of the scientific instrument market. These include the Bruker BioSpin Group, which focuses on magnetic resonance spectroscopy and imaging systems for life sciences and materials research, and the Bruker Optics Group, which offers solutions for molecular spectroscopy and industrial applications. The company also has divisions in areas such as mass spectrometry, X-ray analysis, and nano-analysis.

Bruker operates in over 100 countries worldwide, with its products and services used in academic institutions, government laboratories, pharmaceutical and biotechnology companies, as well as in industries such as materials science, energy, and forensics. The company has established a strong global presence through its subsidiaries, joint ventures, and partnerships. It has acquired various companies over the years to enhance its portfolio and expand its market reach.

In terms of its market position, Bruker is considered a leader in many of the sectors it operates in. It competes with other major scientific instrument companies such as Thermo Fisher Scientific and Agilent Technologies. Bruker reported annual revenues of over $2 billion in 2019 and continues to experience steady growth.

Bruker has achieved several milestones and innovations throughout its history. Notable accomplishments include the development of innovative technologies like the first commercial nuclear magnetic resonance (NMR) spectrometer, advancements in high-resolution mass spectrometry, and breakthroughs in various imaging techniques. These achievements have solidified Bruker's reputation as a trusted provider of cutting-edge solutions for scientific research and analysis.

As of the latest information available, Bruker continues to invest in research and development to further advance its product offerings. The company focuses on expanding its capabilities in areas such as proteomics, drug discovery, and diagnostics. Bruker remains committed to addressing the evolving needs of the scientific community and maintaining its position as a global leader in the scientific instruments market